A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

Condition:   HIV Infections Interventions:   Biological: VH3810109;   Drug: Cabotegravir;   Drug: Standard of care (SOC);   Biological: rHuPH20 Sponsor:   ViiV Healthcare Not yet recruiting

Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials